World Affordable Medicines Congress 2017

World Affordable Medicines Congress is organized by Health Network Communications and would be held during Feb 7 - 8, 2017 at Catalonia Plaza Barcelona Hotel, Barcelona, Cataluna, Spain.

The event unites senior executives from the generic and biosimilar industry to provide fresh insights future market trends, innovative commercial strategies and opportunities for growth for affordable medicines.

The benefits of generics and biosimilars are well celebrated and demand will remain strong as health systems grapple with escalating healthcare costs and austerity measures. However, the industry must continue to overcome barriers including the fluctuating policy environment, increasing competition, the innovator pipeline crisis and pricing pressure. In the rapidly changing market it is critical to adopt the right business strategy.

Through a mixture of plenary keynote sessions, roundtables, focused work streams, the event will address a comprehensive range of key topics, including :
• Making medicines affordable
• CEO Panel
• Building scale and market share
• Mature and emerging market review
• Payers perspective and pricing trends
• Biosimilar development challenges
• Pharmacovogilance and post launch safety monitoring
• Clinical development strategies
• Developments in global intellectual property
• Regulatory strategy for generics and biosimilars
• How is the health policy landscape supporting affordable medicines?
• How to develop an integrated approach to biosimilar development and commercialization

Price :
Group Booking : €1,215 : Book a group of 3+ before 18 November 2016 by saving €135 per person

Speakers : Isabel Afonso, Head of Global Commercial Strategy and member of the Sandoz Executive Committee, Sandoz, Jean-Marie Arnaud, SVP and Head, Sanofi Generics, Sophie Opdyke, Vice President, Commercial Development, Biosimilars, Global Estbalished Pharma BU, Pfizer USA, Darius Panaligan, Vice President, Global Head of Commercial, Merck Biosimilars, Merck